Selective Induction of Activated Treg Cells in Healthy Volunteers for the Treatment of Autoimmune Diseases
American College of Rheumatology
Scientific Publications
Peer-reviewed articles and conference poster presentations
All Scientific Literature Publications
-
Download Poster Selective Induction of Activated Treg Cells in Healthy Volunteers for the Treatment of Autoimmune Diseases
-
Download Poster Development and technical validation of tetramer staining for use as a biomarker for assessing gluten-specific T cells in clinical studies
Development and technical validation of tetramer staining for use as a biomarker for assessing gluten-specific T cells in clinical studies
International Celiac Disease Symposium -
Download Poster Validation of a Gliadin α-I/α-II DQ2 Tetramer Flow Cytometric Assay a Biomarker to Asess Gluten Specific T Cells in Celiac Disease
Validation of a Gliadin α-I/α-II DQ2 Tetramer Flow Cytometric Assay a Biomarker to Asess Gluten Specific T Cells in Celiac Disease
Federation of Clinical Immunology Societies -
Download Poster Epigenetic assays for leukocyte subpopulations identification in sepsis cohort
Epigenetic assays for leukocyte subpopulations identification in sepsis cohort
International Symposium on Intensive Care and Emergency Medicine -
Download Poster Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci
Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci
United European Gastroenterology Week -
Download Poster Etirinotecan pegol Target-Specific Pharmacodynamic (PD) Biomarkers Measured in Circulating Tumor Cells (CTCs) from Patients in the Phase 3 BEACON Study in Patients with
%20Biomarkers%20Measured%20in%20Circulating%20Tumor%20Cells%20(CTCs)%20from%20Patients%20in%20the%20Phase%203%20BEACON%20Study%20in%20Patients%20with.jpg?width=612&height=283&name=108.%20Etirinotecan%20pegol%20Target-Specific%20Pharmacodynamic%20(PD)%20Biomarkers%20Measured%20in%20Circulating%20Tumor%20Cells%20(CTCs)%20from%20Patients%20in%20the%20Phase%203%20BEACON%20Study%20in%20Patients%20with.jpg)
Etirinotecan pegol Target-Specific Pharmacodynamic (PD) Biomarkers Measured in Circulating Tumor Cells (CTCs) from Patients in the Phase 3 BEACON Study in Patients with
American Society of Clinical Oncology -
Download Poster Characterization and Identification of Specific EGFR Mutations in Circulating Tumor Cells (CTCs) Isolated From Non-Small Cell Lung Cancer Patients Using an Antibody Independent Method, ApoStream®
Characterization and Identification of Specific EGFR Mutations in Circulating Tumor Cells (CTCs) Isolated From Non-Small Cell Lung Cancer Patients Using an Antibody Independent Method, ApoStream®
American Society of Clinical Oncology -
Download Poster BRAFV600E mutation analysis in circulating tumor cells
BRAFV600E mutation analysis in circulating tumor cells
American Association for Cancer Research
